Clinical Prognostic Factors in Patients with Locally Advanced (Stage III) Non-small Cell Lung Cancer Treated with Concurrent Hyperfractionated Radiation Therapy and Chemotherapy

被引：0

作者：

Jeremic, B. ^{[1
]}

Milicic, B. ^{[2
]}

机构：

[1] Inst Pulm Dis, Sremska Kamenica, Serbia

[2] Univ Belgrade, Belgrade, Serbia

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2010.07.1188

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S509 / S509

页数：1

共 50 条

[1] Clinical Prognostic Factors in Patients With Locally Advanced (Stage III) Nonsmall Cell Lung Cancer Treated With Hyperfractionated Radiation Therapy With and Without Concurrent Chemotherapy
Jeremic, Branislav
Milicic, Biljana
Milisavljevic, Slobodan
[J]. CANCER, 2011, 117 (13) : 2995 - 3003
[2] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Branislav Jeremić
Biljana Miličić
Slobodan Milisavljevic
[J]. Clinical and Translational Oncology, 2012, 14 : 613 - 618
[3] EVOLUTION OF CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL CELL LUNG CANCER (NSCLC). SINGLE INSTITUTION EXPERIENCE IN 600 PATIENTS
Jeremic, B.
Milicic, B.
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 643 - 643
[4] EVOLUTION OF CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL CELL LUNG CANCER (NSCLC). SINGLE INSTITUTION EXPERIENCE IN 600 PATIENTS
Jeremic, B.
[J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S343 - S344
[5] Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients
Jeremic, Branislav
Milicic, Biljana
Milisavljevic, Slobodan
[J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (08): : 613 - 618
[6] CONCURRENT HYPERFRACTIONATED RADIATION THERAPY AND CHEMOTHERAPY IN LOCALLY ADVANCED (STAGE III) NON-SMALL-CELL LUNG CANCER: SINGLE INSTITUTION EXPERIENCE WITH 600 PATIENTS
Jeremic, Branislav
Milicic, Biljana
Milisavljevic, Slobodan
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (03): : 1157 - 1163
[7] PRETREATMENT PROGNOSTIC FACTORS IN PATIENTS WITH STAGE-III NON-SMALL-CELL LUNG-CANCER TREATED WITH HYPERFRACTIONATED RADIATION-THERAPY WITH OR WITHOUT CONCURRENT CHEMOTHERAPY
JEREMIC, B
SHIBAMOTO, Y
[J]. LUNG CANCER, 1995, 13 (01) : 21 - 30
[8] Pretreatment prognostic factors in stage III non-small cell lung cancer (NSCLC) treated with hyperfractionated radiotherapy (HFX RT) with and without concurrent chemotherapy (CHT)
Jeremic, B
Shibamoto, Y
Acimovic, L
Milisavljevic, S
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1051 - 1051
[9] Accelerated hyperfractionated radiation, concurrent paclitaxel/cisplatin chemotherapy and surgery for stage III non-small cell lung cancer
Adelstein, DJ
Rice, TW
Rybicki, LA
Greskovich, JF
Ciezki, JP
Carroll, MA
DeCamp, MM
[J]. LUNG CANCER, 2002, 36 (02) : 167 - 174
[10] Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer
Lochrin, C
Goss, G
Stewart, DJ
Cross, P
Agboola, O
Dahrouge, S
Tomiak, E
Evans, WK
[J]. LUNG CANCER, 1999, 23 (01) : 19 - 30

← 1 2 3 4 5 →